Clinical outcome of chemoradiotherapy in patients (pts) with limited-disease small-cell lung cancer (LD-SCLC) with ipsilateral pleural effusion

被引：1
|
作者：
Niho, S. [1 ]
Kubota, K. [1 ]
Yoh, K. [1 ]
Goto, K. [1 ]
Ohmatsu, H. [1 ]
Saijo, N. [1 ]
Nishiwaki, Y. [1 ]
机构：
[1] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Do circulating tumour cell (CTC) counts correlate with tumour volume in limited disease small cell lung cancer (LD-SCLC)? An exploratory clinical study with survival outcomes
    Koh, P.
    Hou, J. M.
    Westwood, T.
    Cain, J.
    Webster, G.
    Priest, L.
    Sloane, R.
    Krebs, M.
    Faivre-Finn, C.
    Dive, C.
    Blackhall, F.
    LUNG CANCER, 2012, 75 : S60 - S60
  • [42] Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancer
    Sekine, Ikuo
    Sumi, Minako
    Satouchi, Miyako
    Tsujino, Kayoko
    Nishio, Makoto
    Kozuka, Takuyo
    Niho, Seiji
    Nihei, Keiji
    Yamamoto, Nobuyuki
    Harada, Hideyuki
    Ishikura, Satoshi
    Tamura, Tomohide
    CANCER SCIENCE, 2016, 107 (03) : 315 - 319
  • [43] The role of surgery in limited-disease small cell lung cancer (SCLC); a retrospective comparative study.
    Badzio, A
    Kurowski, K
    Karnicka-Miodkowska, H
    Jassem, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 671S - 671S
  • [44] Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions
    Ohara, Sayaka
    Kanda, Shintaro
    Okuma, Hitomi
    Goto, Yasushi
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Ito, Yoshinori
    Yamamoto, Noboru
    Usui, Kazuhiro
    Homma, Sakae
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (01) : 82 - 88
  • [45] Radiochemotherapy in special populations with limited-disease small-cell lung cancer and locally advanced non-small-cell lung cancer
    Rios, Ivan
    Morales, Javier
    Vinolas, Nuria
    Casas, Francesc
    LUNG CANCER MANAGEMENT, 2012, 1 (01) : 63 - 71
  • [46] HYPERFRACTIONATED RADIOTHERAPY AND PROPHYLACTIC CRANIAL IRRADIATION IN THE ROUTINE TREATMENT OF PATIENTS WITH LIMITED-DISEASE SMALL-CELL LUNG CANCER
    Wzietek, Iwona
    Bialas, Marcin
    Gawkowska-Suwinska, Marzena
    Nowara, Elzbieta
    Suwinski, Rafal
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1340 - S1341
  • [47] Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival
    Farkhad Manapov
    Sabine Klöcking
    Maximilian Niyazi
    Victor Levitskiy
    Claus Belka
    Guido Hildebrandt
    Rainer Fietkau
    Gunther Klautke
    Journal of Neuro-Oncology, 2012, 109 : 309 - 314
  • [48] Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival
    Manapov, Farkhad
    Kloecking, Sabine
    Niyazi, Maximilian
    Levitskiy, Victor
    Belka, Claus
    Hildebrandt, Guido
    Fietkau, Rainer
    Klautke, Gunther
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 309 - 314
  • [49] Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
    Bernhardt, Denise
    Aufderstrasse, Sophie
    Koenig, Laila
    Adeberg, Sebastian
    Bozorgmehr, Farastuk
    Christopoulos, Petros
    El Shafie, Rami A.
    Hoerner-Rieber, Juliane
    Kappes, Jutta
    Thomas, Michael
    Herth, Felix
    Steins, Martin
    Debus, Juergen
    Rieken, Stefan
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6563 - 6569
  • [50] The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer
    Endo, Satoshi
    Imai, Hisao
    Shiono, Ayako
    Hashimoto, Kosuke
    Miura, Yu
    Okazaki, Shohei
    Abe, Takanori
    Mouri, Atsuto
    Kaira, Kyoichi
    Masubuchi, Ken
    Masubuchi, Takeshi
    Kobayashi, Kunihiko
    Minato, Koichi
    Kato, Shingo
    Kagamu, Hiroshi
    ONCOLOGY, 2024,
12345